CoronaryAtlas logo
CoronaryAtlas
ASCVD Risk Atlas
← Back to table
A

Leptin

Novel & Emerging BiomarkersLab test / biomarkerriskpartially modifiable
35
evidence score
PREVENT status

Not a PREVENT input variable.

Causal support

trial evidence

Score components
lit volume: 15.2meta-analyses: 13.8trials: 6genetic: 0MR bonus:

References (32)

4 meta-analyses / systematic reviews

Clinical trials (3)

NCTTitleStatusTypeInterventions
NCT07220772An Open-Label Study of Mibavademab (REGN4461), a Leptin Receptor Agonist, for the Treatment of Monogenic Obesity Due to Biallelic Loss of Function Variants of the LEP GeneRECRUITINGINTERVENTIONALMibavademab
NCT03377465Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and PrognosisCOMPLETEDINTERVENTIONALADMA (asymmetric dimethylarginine) , NTproBNP (N-terminal pro b-type natriuretic peptide), IL-6 (Interleukin 6), Adiponectina, Leptine, Syndecan, Resistin
NCT00659828Effects of Leptin Replacement in ChildrenCOMPLETEDINTERVENTIONALRecombinant methionyl human leptin

Genetic associations (0)

None linked.